Your browser doesn't support javascript.
loading
Self-Assembly Protein Nanogels for Safer Cancer Immunotherapy.
Purwada, Alberto; Tian, Ye F; Huang, Weishan; Rohrbach, Kathleen M; Deol, Simrita; August, Avery; Singh, Ankur.
Afiliação
  • Purwada A; Meinig School of Biomedical Engineering, College of Engineering, Cornell University, Ithaca, NY, 14853, USA.
  • Tian YF; Sibley School of Mechanical and Aerospace Engineering, College of Engineering, Cornell University, Ithaca, NY, 14853, USA.
  • Huang W; Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA.
  • Rohrbach KM; Department of Material Science and Engineering, College of Engineering, Cornell University, Ithaca, NY, 14853, USA.
  • Deol S; Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA.
  • August A; Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, NY, 14853, USA.
  • Singh A; Sibley School of Mechanical and Aerospace Engineering, College of Engineering, Cornell University, Ithaca, NY, 14853, USA.
Adv Healthc Mater ; 5(12): 1413-9, 2016 06.
Article em En | MEDLINE | ID: mdl-27100566
ABSTRACT
Soluble antigen-based cancer vaccines have poor retention in tissues along with suboptimal antigen processing by dendritic cells. Multiple booster doses are often needed, leading to dose-limiting systemic toxicity. A versatile, immunomodulatory, self-assembly protein nanogel vaccine is reported that induces robust immune cell response at lower antigen doses than soluble antigens, an important step towards biomaterials-based safer immunotherapy approaches.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Nanopartículas / Imunoterapia / Antígenos de Neoplasias / Proteínas de Neoplasias / Neoplasias Limite: Animals / Humans Idioma: En Revista: Adv Healthc Mater Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Nanopartículas / Imunoterapia / Antígenos de Neoplasias / Proteínas de Neoplasias / Neoplasias Limite: Animals / Humans Idioma: En Revista: Adv Healthc Mater Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Estados Unidos